newest glp 1 agonist GLP-1: Genetic Variants Related to GLP-1 RA Medications GLP-1 Receptor Agonist Market Size

One such agent that has captured significant attention are GLP-1 agonists

Research shows that taking GLP-1 receptor agonists may increase a persons risk of developing certain vision problems, including NAION, which can cause sudden, painless vision loss in one eye due to reduced blood flow in the optic nerve

For the placebo arm, there were 20 recorded medications, 100% (14/14) of patients were treated with metformin, 14.3% (2/14) were on dapagliflozin, 7.1% (1/14) were treated with either gliclazide, Humulin I, Insulutard or Victoza

In comparison to previous systematic reviews and meta-analyses, we were able to perform subgroup analyses based on the duration of treatment with GLP-1RAs

The risk calculus changes accordingly